IONTAS is a biotechnology company formed in Cambridge, UK, in 2014 in order to advance the development of novel antibody therapeutics. Established on research of the founder, John McCafferty, it employs proprietary technologies and services in all key areas of therapeutic antibody discovery and development. The company applies expertise in antibody engineering and assay development to ensure projects are delivered within specification and timeframe. Our services are tailored to the specific requirements of each Partner, which facilitates delivery of project objectives in a timely manner. Further to the services offered by IONTAS, we are seeking to partner with select companies to develop new antibody based therapies in the areas of cancer and inflammation.